Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...

Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company's ambitions to expand its commercialisation activities and advance its innovati ...

New American Red Cross data reveals that 1 in 5 blood donors have elevated A1C levels — a sign that prediabetes and diabetes are prevalent among adults in generally good health.

MiniMed Group, the diabetes business of Medtronic, filed Tuesday to raise up to $784 million in an initial public offering. The Northridge, California-based firm p ...

InnovaMatrix revenue is expected to fall to approximately $20 million in 2026 from $69 million in 2025, a decline of roughly 71%, representing a headwind of approximately 2% of group revenue.

Feel tired, foggy, or irritable after eating? Learn how blood sugar spikes can happen even with a normal A1C — and what to do about them.

The scientists will develop the Human Flatus Atlas, which quantifies the dynamic range of intestinal gas production. Read ...

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine bloodwork long before diagnosis.

Tandem Diabetes tops Q4 estimates with narrower loss, 15% revenue jump and wider gross margin, sending shares up 6.7% after hours.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetesMANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ...